Rusella Mirza, MD
Anatomic Pathology & Clinical Pathology · Shreveport, LANPI 1346786076
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AstraZeneca at 28.7% of the total. 2025 is the largest year on record at $591, 5.2 times the $113 reported in 2023. Among anatomic pathology & clinical pathology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $29.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$275
- Tempus AI, Inc$140
- Lilly USA, LLC$95
- Genentech USA, Inc.$84
- Jazz Pharmaceuticals Inc.$46
- Regeneron Healthcare Solutions, Inc.$44
- plus $274 from 10 others
What the payments were for
- Food & beverage$959100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $275 |
| Tempus AI, Inc | 6 | $140 |
| Lilly USA, LLC | 1 | $95 |
| Genentech USA, Inc. | 5 | $84 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Roche Diagnostics Corporation | 1 | $39 |
| Recordati_rare_diseases_inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $34 |
| Pharmacosmos Therapeutics Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Novartis | 1 | $25 |
| Boehringer Ingelheim | 1 | $21 |
| Merck | 1 | $16 |
| Regeneron | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$125
How this compares
$959 in reported general payments places this provider in the 90th percentile of 132 anatomic pathology & clinical pathology providers in Louisiana.
See all anatomic pathology & clinical pathology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Shreveport
- Aaron CotrellShreveport$8K
- Fredric SiskronShreveport$1K
- Menchu OngShreveport$598
- Fleurette AbreoShreveport$510
- Ammoura IbrahimShreveport$426
- Susan VeillonShreveport$421
- Kshitij AroraShreveport$386
- Xin GuShreveport$367
- Adaugo NwangumaShreveport$205
- Bernadette McLarenShreveport$196
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.